All News #Library
Biotech
Centauri Therapeutics Granted FDA QIDP Status For CTX-187
10 Mar 2026 //
BUSSINESSWIRE
Centauri Gets Extra $5.1M from CARB-X for ABX-01 Clinical Trials
29 Jul 2025 //
BUSINESSWIRE
Centauri Selects First Clinical Candidate For Gram-Negative Infections
04 Mar 2025 //
BUSINESSWIRE

Market Place
Sourcing Support